Evidence map›Paper›PMID 29923072›Full record

ArticleSocial psychiatry and psychiatric epidemiology2018

Symptomatic and functional recovery in depression in later life.

Rose M Collard, Sanne Wassink-Vossen, Aart H Schene, Paul Naarding, Peter Verhaak, Richard C Oude Voshaar, Hannie C Comijs

Open access · hybridAbstract read
In one paragraph

Article in Social psychiatry and psychiatric epidemiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Functional improvement by behavioural activation for depressed older adults.European psychiatry : the journal of the Association of European Psychiatrists · 2023
    Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 1 country.

Rose M CollardDepartment of Psychiatry, Radboud University Medical Center, Nijmegen, The Netherlands. rose.collard@radboudumc.nl.
Sanne Wassink-VossenDepartment of Old-age Psychiatry, GGNet, Apeldoorn, Zutphen, The Netherlands.
Aart H ScheneDepartment of Psychiatry, Radboud University Medical Center, Nijmegen, The Netherlands.
Paul NaardingDepartment of Old-age Psychiatry, GGNet, Apeldoorn, Zutphen, The Netherlands.
Peter VerhaakDepartment General Practice, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Richard C Oude VoshaarUniversity Medical Center Groningen, University Center for Psychiatry, University of Groningen, Groningen, The Netherlands.
Hannie C ComijsGGZinGeest, Amsterdam, The Netherlands.
GGNet · NLAmsterdam UMC Location VUmc · NLRadboud University Medical Center · NLRadboud University Nijmegen · NLUniversity Medical Center Groningen · NLUniversity of Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesFunctional limitations give an indication of the total impact of diseases, such as depression, on individuals health and recovery. This study examines the change in several domains of functioning over 2 years in older persons depressed at baseline (non-remitted group and remitted group after 2 years) and in a non-depressed comparison group.

methodsData were used from a cohort study (Netherlands Study of Depression in Older persons [NESDO]) consisting of depressed older persons ≥ 60 years (N = 378) and a non-depressed comparison group (N = 132) with 2 years of follow-up (attrition rate 24%). Functional limitations (outcome) were assessed with the World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) questionnaire every 6 months. Total scores and domain scores were used. Depression was classified according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria at baseline and at 2-year follow-up. Severity of depression (predictor) was assessed with the Inventory of Depressive Symptomatology (IDS) at 6-month intervals.

resultsLinear mixed models showed that the level of functional limitations differed between the three groups during 2 years of follow-up. The non-remitted group had the highest level of functional limitations during 2 years, followed by the remitted group. Stable low levels of functional limitations were found for the non-depressed group. Remission from depression was accompanied by improvements in functioning, however, compared to the non-depressed comparison group significant functional limitations remained. Higher severity of depression appeared as risk factor for a declining course of functioning, especially the social aspects of functioning. METHODOLOGICAL CONSIDERATIONS: Participants that were more severely depressed and more functionally impaired at baseline had higher attrition rates than the participants that were included in the analytical sample.

conclusionThis study showed that depression in later life has long-term debilitating effects on functioning, enduring even after remission from depression. This implies that depression treatment in later life should aim broader than just symptomatic recovery, but also include functional recovery.

Indexed as

Age FactorsRecovery of FunctionSeverity of Illness IndexAgedAged, 80 and overCohort StudiesDepressionDisability EvaluationFemaleHumansLinear ModelsMaleMiddle AgedNetherlandsRisk FactorsSurveys and QuestionnairesFunctional limitationsLate-life depressionNetherlands Study of Depression in Older personsRemission

Identifiers

PMID29923072
PMCPMC6182497
OpenAlexW2808891554

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.